Double immunotherapy attack after Chemo-Radiation shows promise for lung cancer
Disease control
Completed
This study tested whether adding two immunotherapy drugs (nivolumab and ipilimumab) after standard chemoradiation could better control stage III lung cancer compared to nivolumab alone. 105 patients were randomly assigned to one of the two treatment groups. The main goal was to s…
Phase: PHASE2 • Sponsor: Greg Durm, MD • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC